RecruitingNot ApplicableNCT05510401

Evaluation of Safe Use of SECURIDRAP® SELFIA®

Multicenter Clinical Investigation for the Evaluation of Safe Use of SECURIDRAP® SELFIA®


Sponsor

Groupe Mulliez-Flory

Enrollment

108 participants

Start Date

May 18, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Interventional, multicenter, prospective and non-comparative clinical investigation carried out in 9 French establishments in order to assess the safety of the SÉCURIDRAP® SELFIA® bedding by mesasuring all the adverse events likend to its use. Following the withdrawal from the market of the first version of the SECURIDRAP® SELFIA®, this clinical investigation is being carried out at the request and on the recommandation of the ASNM in order to assess the safety of the second version of the SECURIDRAP® SELFIA® coating.


Eligibility

Min Age: 18 Years

Inclusion Criteria9

  • Patient at least 18 years old
  • Patient having a medical prescription for SÉCURIDRAP® SELFIA®
  • Patient in phase or state of disorientation
  • Patient with nocturnal behavior disordre
  • Patient with major cognitive impairment
  • Patient at risk of falling into bed
  • Patient subject to guardianship or curatorship
  • Patient beneficiary or affiliated to a social security scheme
  • Patient who has given their participation agreement aand informed consent

Exclusion Criteria10

  • Patient and/or guardianship or curatorship refusing to agree to participate in the clinical investigation
  • Patient in psychiatry
  • Patient with severe agitation
  • Patient who will be agitated once installed in the SÉCURIDRAP® SELFIA®
  • Patient with intolerance to the medical device
  • Patient able to extract himself from SÉCURIDRAP® SELFIA®
  • Patient able to unlock the bed rails by himself
  • Patient without social coverage or not benefiting from it through a third party
  • Patient minor, pregnant woman, persons deprived of their liberty
  • Patient who participating or having participated in another clinical investigation, drug or medical device in the 30 days preceding inclusion

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSECURIDRAP® SELFIA®

Use of SECURIDRAP® SELFIA® for 15 night


Locations(10)

CMMF de Bailleul

Bailleul, France

EHPAD l'Aquarelle

Bully-les-Mines, France

Centre Hospitalier d'Hazebrouck

Hazebrouck, France

Centre Hospitalier Le Quesnoy

Le Quesnoy, France

CHU Lille

Lille, France

Ussap- Asm Limoux

Limoux, France

CHU Lyon

Lyon, France

CHU Rennes

Rennes, France

CHG Roubaix

Roubaix, France

CSSR La Clauze

Saint-Jean-Delnous, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05510401


Related Trials